EAHAD/LinkedIn
May 21, 2026, 07:23
EAHAD Highlights the Power of Clinical Trials in Haemophilia
EAHAD (European Association for Haemophilia and Allied Disorders) shared a post on LinkedIn:
“This Clinical Trials Day, we recognize the critical role that clinical research plays in driving innovation and improving outcomes for people living with haemophilia.
Within this context, the EAHAD Gene Therapy Trials Database provides a publicly accessible resource that consolidates the latest published gene therapy data, with a particular focus on safety outcomes.
By bringing structured and up-to-date evidence into one place, the platform supports a clearer understanding of ongoing and completed clinical research in the field.
Access the database.”
Stay updated with Hemostasis Today.
-
Jul 5, 2026, 21:06Heghine Khachatryan: Toward Personalized Management of Glanzmann Thrombasthenia
-
Jul 5, 2026, 21:06Priyanka Kumari: IV Fluids and Isotonic Solution
-
Jul 5, 2026, 21:05Ahmed Rizq: Would You Thrombolyse a Stable Patient?
-
Jul 5, 2026, 21:03Emmanuel Obeng Ofori: Diagnosing Anaemia – Why Treating the Root Cause Matters More Than Simply Raising the Haemoglobin
-
Jul 5, 2026, 21:02Mohit Koladia: The Pharmacist’s Role in Stroke Prevention for Atrial Fibrillation
-
Jul 5, 2026, 20:22J. Meireles-Brandao: Exploring the Approach to Thrombophillias
-
Jul 5, 2026, 20:13Kavya Keerthana: The Platelet Count Everyone Calls ‘Reactive’ Until It Isn’t
-
Jul 5, 2026, 20:00Paul Kariuki: Why Altruism Isn’t Enough to Save Kenya’s Blood System
-
Jul 5, 2026, 19:53Tareq Abadl: Post-Transfusion Reactions – Can You Identify the Cause?